CCCC(=O)N[C@@H](Cc1cc(I)c(O)c(I)c1)C(=O)NCCCNCCCCNCCCNC(=O)[C@@H](N)CCCN=C(N)N.O=C(O)C(F)(F)F
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?